Ackermans & van Haaren

Ackermans & van Haaren is a diversified investment group based in Antwerp, Belgium, founded in 1876. The firm operates across five key segments: Marine Engineering & Infrastructure, Private Banking, Real Estate and Senior Care, Energy and Resources, and Development Capital. In the Marine Engineering and Infrastructure sector, it includes DEME, a prominent global dredging company, and Algemene Aannemingen Van Laere, a leading Belgian contractor. Ackermans & van Haaren focuses on creating shareholder value through long-term investments in select companies with significant growth potential on an international scale. With a commitment to fostering development in these sectors, the group aims to support businesses that are well-positioned for expansion and success.

John-Eric Bertrand

Co-CEO and Co-Chairman of the Executive Committee

Jeroen Vangindertael Ph.D

Investment Manager

Past deals in Belgium

Biotalys

Post in 2024
Biotalys NV is an agricultural technology company based in Ghent, Belgium, that specializes in the research and development of biopesticides aimed at controlling pests and diseases affecting crops and harvested products. The company utilizes its proprietary Agrobody technology platform to create protein-based crop protection solutions that effectively bind to leaves, seeds, and fruits, enabling targeted delivery of active ingredients. This innovative approach combines the performance of traditional chemical pesticides with the safety profile of biological alternatives, making Biotalys' products suitable for both pre- and post-harvest applications. Founded in 2013, Biotalys is committed to providing sustainable and safe food protection solutions, positioning itself as a leader in the evolution of agricultural practices.

MRM Health NV

Series A in 2020
MRM Health NV is a biopharmaceutical company based in Ghent, Belgium, that specializes in developing microbiome-based therapeutics for metabolic diseases. Founded in early 2020 as a subsidiary of MRM Technologies, the company collaborates with the Flemish Institute of Biotechnology (VIB) to translate scientific research into practical applications. MRM Health is focused on innovative drug development, particularly its lead candidate MH002, aimed at treating Inflammatory Bowel Disease (IBD), which encompasses conditions such as Ulcerative Colitis and Crohn's disease. Through its research and development efforts, MRM Health seeks to advance therapeutic options based on the human microbiome.

Biotalys

Series C in 2019
Biotalys NV is an agricultural technology company based in Ghent, Belgium, that specializes in the research and development of biopesticides aimed at controlling pests and diseases affecting crops and harvested products. The company utilizes its proprietary Agrobody technology platform to create protein-based crop protection solutions that effectively bind to leaves, seeds, and fruits, enabling targeted delivery of active ingredients. This innovative approach combines the performance of traditional chemical pesticides with the safety profile of biological alternatives, making Biotalys' products suitable for both pre- and post-harvest applications. Founded in 2013, Biotalys is committed to providing sustainable and safe food protection solutions, positioning itself as a leader in the evolution of agricultural practices.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.